FDA Inspection 992472 — Chartwell Pharmaceuticals Congers, LLC
The FDA completed an inspection of Chartwell Pharmaceuticals Congers, LLC on Nov 1, 2016 in Congers, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 1, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Congers, NY (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)